Cargando…

Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer

SIMPLE SUMMARY: Hypoxia in solid tumors is common in most solid cancers and is associated with treatment resistance to both chemo- and radiation-therapy. There is also reason to believe that hypoxia is an important determinant of metastic disease. Identifying hypoxia in solid tumors is important in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, Torgeir, Brandal, Siri Helene Bertelsen, Köhn-Luque, Alvaro, Engebraaten, Olav, Kristensen, Vessela N., Fleischer, Thomas, Hompland, Tord, Seierstad, Therese
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909402/ https://www.ncbi.nlm.nih.gov/pubmed/35267636 http://dx.doi.org/10.3390/cancers14051326

Ejemplares similares

MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients
por: Mo, Torgeir, et al.
Publicado: (2023)

A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients
por: Salberg, Unn Beate, et al.
Publicado: (2022)

Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
por: Hompland, Tord, et al.
Publicado: (2021)

Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
por: Fjeldbo, Christina S., et al.
Publicado: (2020)

Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial
por: Engebraaten, Olav, et al.
Publicado: (2012)

miR‐200a/b/‐429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer
por: Nilsen, Anja, et al.
Publicado: (2022)

Unsupervised clustering of gene expression data points at hypoxia as possible trigger for metabolic syndrome
por: Ptitsyn, Andrey, et al.
Publicado: (2006)

Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer()()
por: Bousquet, Paula A., et al.
Publicado: (2018)

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
por: Fangberget, A., et al.
Publicado: (2010)

Impact of tissue transport on PET hypoxia quantification in pancreatic tumours
por: Taylor, Edward, et al.
Publicado: (2017)

Hypoxia. Hypoxia, hypoxia inducible factor and myeloid cell function
por: Walmsley, Sarah R, et al.
Publicado: (2009)

Inter-reader agreement of (18)F-FDG PET/CT for the quantification of carotid artery plaque inflammation
por: Johnsrud, Kjersti, et al.
Publicado: (2020)

Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
por: Jonsson, Marte, et al.
Publicado: (2016)

Tumor hypoxia causes DNA hypermethylation by reducing TET activity
por: Thienpont, Bernard, et al.
Publicado: (2016)

Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis
por: Beyer, Christian, et al.
Publicado: (2009)

Hypoxia and Hypoxia-Inducible Factors in Leukemias
por: Deynoux, Margaux, et al.
Publicado: (2016)

Hypoxia and hypoxia-inducible factors in neuroblastoma
por: Påhlman, Sven, et al.
Publicado: (2017)

Hypoxia and Hypoxia-Inducible Factors in Lymphedema
por: Jiang, Xinguo, et al.
Publicado: (2022)

Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging
por: Carmona-Bozo, Julia C., et al.
Publicado: (2020)

Arginine:Glycine Amidinotransferase Is Essential for Creatine Supply in Mice During Chronic Hypoxia
por: Hannemann, Juliane, et al.
Publicado: (2021)

Maternal Hypoxia Decreases Capillary Supply and Increases Metabolic Inefficiency Leading to Divergence in Myocardial Oxygen Supply and Demand
por: Hauton, David, et al.
Publicado: (2015)

The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
por: Ragnum, H B, et al.
Publicado: (2015)

Hypoxia
por: Gray, Frank D.
Publicado: (1964)

Sestrin2 in hypoxia and hypoxia-related diseases
por: Che, Xiaojing, et al.
Publicado: (2021)

Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis
por: Foglia, Beatrice, et al.
Publicado: (2021)

(18)F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques
por: Johnsrud, Kjersti, et al.
Publicado: (2017)

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
por: Lindholm, Evita Maria, et al.
Publicado: (2019)

Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2012)

Automatic Quantification of Microvessels Using Unsupervised Image Analysis
por: Ranefall, Petter, et al.
Publicado: (1998)

Unpaired MR-CT brain dataset for unsupervised image translation
por: Al-Kadi, Omar S., et al.
Publicado: (2022)

Hypoxia and oxidative stress in breast cancer: Hypoxia and tumourigenesis
por: Knowles, Helen J, et al.
Publicado: (2001)

HypoxiaDB: a database of hypoxia-regulated proteins
por: Khurana, Pankaj, et al.
Publicado: (2013)

Hypoxia and Hypoxia-Inducible Factors in Kidney Injury and Repair
por: Shu, Shaoqun, et al.
Publicado: (2019)

DCE-MRI of Tumor Hypoxia and Hypoxia-Associated Aggressiveness
por: Gaustad, Jon-Vidar, et al.
Publicado: (2020)

Hypoxia in Alzheimer’s disease: effects of hypoxia inducible factors
por: Hassan, Halimatu, et al.
Publicado: (2020)

Hypoxia and hypoxia-inducible factors in diabetes and its complications
por: Catrina, Sergiu-Bogdan, et al.
Publicado: (2021)

Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
por: Li, Yue, et al.
Publicado: (2021)

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
por: Normann, Lisa Svartdal, et al.
Publicado: (2023)

Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO(2) saturation measurements
por: Fenton, B M, et al.
Publicado: (1999)

In Vivo Imaging and Quantification of Carbonic Anhydrase IX Expression as an Endogenous Biomarker of Tumor Hypoxia
por: Bao, Bagna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jtdhj2scndkdf4dad1er782ugr